Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuria. H Erlandsen, F Fusetti, A Martinez, E Hough, T Flatmark, RC Stevens Nature structural biology 4 (12), 995-1000, 1997 | 256 | 1997 |
The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency N Blau, H Erlandsen Molecular genetics and metabolism 82 (2), 101-111, 2004 | 250 | 2004 |
The structural basis of phenylketonuria H Erlandsen, RC Stevens Molecular genetics and metabolism 68 (2), 103-125, 1999 | 238 | 1999 |
Three-Dimensional Structure of Human Tryptophan Hydroxylase and Its Implications for the Biosynthesis of the Neurotransmitters Serotonin and Melatonin, L Wang, H Erlandsen, J Haavik, PM Knappskog, RC Stevens Biochemistry 41 (42), 12569-12574, 2002 | 229 | 2002 |
Structure of tetrameric human phenylalanine hydroxylase and its implications for phenylketonuria F Fusetti, H Erlandsen, T Flatmark, RC Stevens Journal of Biological Chemistry 273 (27), 16962-16967, 1998 | 226 | 1998 |
Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations H Erlandsen, AL Pey, A Gámez, B Pérez, LR Desviat, C Aguado, R Koch, ... Proceedings of the National Academy of Sciences 101 (48), 16903-16908, 2004 | 222 | 2004 |
A specific IFIH1 gain-of-function mutation causes Singleton-Merten syndrome F Rutsch, M MacDougall, C Lu, I Buers, O Mamaeva, Y Nitschke, GI Rice, ... The American Journal of Human Genetics 96 (2), 275-282, 2015 | 217 | 2015 |
PAHdb 2003: What a locus‐specific knowledgebase can do CR Scriver, M Hurtubise, D Konecki, M Phommarinh, L Prevost, ... Human mutation 21 (4), 333-344, 2003 | 211 | 2003 |
Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations AL Pey, B Pérez, LR Desviat, MA Martínez, C Aguado, H Erlandsen, ... Human mutation 24 (5), 388-399, 2004 | 159 | 2004 |
Crystal Structure and Site-Specific Mutagenesis of Pterin-Bound Human Phenylalanine Hydroxylase, H Erlandsen, E Bjørgo, T Flatmark, RC Stevens Biochemistry 39 (9), 2208-2217, 2000 | 146 | 2000 |
Trends in enzyme therapy for phenylketonuria W Kim, H Erlandsen, S Surendran, RC Stevens, SK Tyring, R Matalon, ... Molecular Therapy 10 (2), 220-224, 2004 | 120 | 2004 |
A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria H Erlandsen, RC Stevens Journal of inherited metabolic disease 24 (2), 213-230, 2001 | 105 | 2001 |
Structural studies on phenylalanine hydroxylase and implications toward understanding and treating phenylketonuria H Erlandsen, MG Patch, A Gamez, M Straub, RC Stevens Pediatrics 112 (Supplement_4), 1557-1565, 2003 | 98 | 2003 |
Structural comparison of bacterial and human iron-dependent phenylalanine hydroxylases: similar fold, different stability and reaction rates H Erlandsen, JY Kim, MG Patch, A Han, A Volner, MM Abu-Omar, ... Journal of molecular biology 320 (3), 645-661, 2002 | 94 | 2002 |
Crystallographic Analysis of the Human Phenylalanine Hydroxylase Catalytic Domain with Bound Catechol Inhibitors at 2.0 Å Resolution, H Erlandsen, T Flatmark, RC Stevens, E Hough Biochemistry 37 (45), 15638-15646, 1998 | 92 | 1998 |
The highly conserved domain of unknown function 1792 has a distinct glycosyltransferase fold H Zhang, F Zhu, T Yang, L Ding, M Zhou, J Li, SM Haslam, A Dell, ... Nature communications 5 (1), 4339, 2014 | 83 | 2014 |
Biopterin responsive phenylalanine hydroxylase deficiency R Matalon, R Koch, K Michals-Matalon, K Moseley, S Surendran, S Tyring, ... Genetics in Medicine 6 (1), 27-32, 2004 | 83 | 2004 |
Combining structural genomics and enzymology: completing the picture in metabolic pathways and enzyme active sites H Erlandsen, EE Abola, RC Stevens Current Opinion in Structural Biology 10 (6), 719-730, 2000 | 71 | 2000 |
HEPN: a common domain in bacterial drug resistance and human neurodegenerative proteins M Grynberg, H Erlandsen, A Godzik Trends in biochemical sciences 28 (5), 224-226, 2003 | 68 | 2003 |
Drugging the folate pathway in Mycobacterium tuberculosis: the role of multi-targeting agents B Hajian, E Scocchera, C Shoen, J Krucinska, K Viswanathan, ... Cell chemical biology 26 (6), 781-791. e6, 2019 | 58 | 2019 |